Back to search

Article

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

2018-12-14

Abstract excerpt

<h4>Background</h4> Triple-negative breast cancers are poor-prognosis tumors characterized by absence of molecular signature and are chemotherapy is still the only systemic treatment. Currently, research focus to identify biomarkers that may be usable for prognosis and/or for treatment, notably among the proteins involved in cell migration and metastatic capacity. <h4>Methods</h4> We used proteomic approach to i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6b2b24c-7d62-5a7f-b8e9-9b388cb76500
DOI
10.1101/496026
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancerDOI 10.1101/496026
Select a neighboring publication to make it the new centre.